RACGAP1 and posterior cortical atrophy: Concomitant inhibition of AR transcriptional pathway activity with enzalutamide and depletion of RACGAP1 using an in vivo siRNA system exhibited more potent suppression of PCa xenografts than either enzalutamide or siRACGAP1 alone.